Abstract
Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by abnormal myocardial hypertrophy, which can lead to a wide clinical spectrum, including sudden cardiac death and heart failure. Cardiac MRI has a significant role in establishing the diagnosis of HCM. In the three principal management issues related to HCM; testing of family members of affected individuals; assessing the risk of sudden cardiac death from lethal ventricular arrhythmias; and selection of appropriate treatments for left ventricular outflow obstruction, cardiac MRI has established or emerging roles.
Original language | English (US) |
---|---|
Pages (from-to) | 697-709 |
Number of pages | 13 |
Journal | Future Cardiology |
Volume | 9 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2013 |
Keywords
- Cardiac MRI
- Cardiomyopathy
- Hypertrophic cardiomyopathy
- Late gadolinium enhancement
- Sudden cardiac death
ASJC Scopus subject areas
- Molecular Medicine
- Cardiology and Cardiovascular Medicine